Table 1.

Clinical characteristics of patients undergoing PCI receiving bivalirudin

Clinical characteristics (n = 66)	Values
Age (years, mean, ± SD)	64.8 ± 9.7
Female (n, %)	29 (43.9 %)
Height (cm ± SD)	168.0 ± 12.3
Weight (kg ± SD)	86.0 ± 22.6
Body mass index (BMI)	30.3 ± 7.0
Systolic blood pressure (mmHG ± SD)	139.2 ± 19.4
Diastolic blood pressure (mmHG ± SD)	77.8 ± 12.0
Fasting blood glucose (mg/dl ± SD)	132 ± 61.3
Diabetes mellitus (n, %)	17 (25.8 %)
Unstable angina/NSTEMI (n, %)	14 (21.2 %)
Smokers (n, %)	11 (16.7 %)
Number of stents per patient (mean + SD)	1.6 + 0.9
Medications before PCI (n, %)
ASA	61 (92.4 %)
Clopidogrel	53 (80.3 %)
b blocker	42 (63.6 %)
ACE inhibitor	27 (40.9 %)
Angioten sin II receptor blocker	9 (13.6 %)
Ca channel blocker	21 (31.8 %)
Statin	38 (68.2 %)
Lipid lowering (excluding statin)	18 (27.3 %)
Diuretic	21 (31.8 %)
Nitrates	15 (22.7 %)

Out of the 14 patients presenting with unstable angina and NSTEMI, two had a NSTEMI. Ethnicity was 89.4 % Caucasian with 10.6 % African American patients